Health policy and outcomes 2006

Stroke

Volumn 38, Issue 2, 2007, Pages 229-231

  Lyons, Renee ^c   Rudd, Anthony G ^a,b  

^a ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Advances in stroke; Health burden; Health economics; Health policy; Outcomes research; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTICOAGULANT THERAPY; COST EFFECTIVENESS ANALYSIS; DEVELOPED COUNTRY; DISABILITY ADJUSTED LIFE YEARS; ECONOMIC EVALUATION; EDUCATION PROGRAM; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH EDUCATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; NEUROSURGERY; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SHORT SURVEY; STANDARD; STROKE; TELEMEDICINE;

CEREBROVASCULAR ACCIDENT; COST OF ILLNESS; HEALTH POLICY; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 33846561616     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254943.29376.e8     Document Type: Short Survey

References (28)

1. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, Gutnikov SA, Edwards P, Mant D, Sackley CM, Farmer A, Sandercock PA, Dennis MS, Warlow CP, Bamford JM, Anslow P; Oxford Vascular Study. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet. 2004;12:363:1925-1933.
2. Truelsen T, Piechowski-Jóźwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data. Eur J Neurol. 2006;13:581-598.
3. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol. 2006;100:481-499.
4. Lemogoum D, Degaute JP, Bovet P. Stroke prevention, treatment, and rehabilitation in Sub-Saharan Africa. Am J Prev Med. 2005 Dec;29(Suppl 1):95-101.
5. Wolfe CD, Corbin DO, Smeeton NC, Gay GH, Rudd AG, Hennis AJ, Wilks RJ, Fraser HS. Estimation of the risk of stroke in black populations in Barbados and South London Stroke. 2006;37:1986-1990.
6. National Audit Office/Department of Health (NAO/DOH). Reducing Brain Damage: Faster Access To Better Stroke Care. London: The Stationery Office; 2005.
7. Moodie M, Cadilhac D, Pearce D, Milalopoulos C, Carter R, Davis S, Donnan G. Economic evaluation of Australian Stroke services: a prospective, multicentre study comparing dedicated stroke units with other care modalities. Stroke. 2006;37:2790-2795.
8. Struijs JN, van Genugten ML, Evers SM, Ament AJ, Baan CA, van den Bos GA. Future costs of stroke in the Netherlands: the impact of stroke services. Int J Technol Assess Health Care. 2006;22:518-524.
9. Brown DL, Boden-Albala B, Langa KM, Lisabeth LD, Fair M, Smith MA, Sacco RL, Morgenstern LB. Projected costs of ischemic stroke in the United States. Neurology. 2006;67:1390-1395.
10. Galloway JM. Cardiovascular health among American Indians and Alaska Natives: successes, challenges, and potentials. Am J Prev Med. 2005;29(Suppl 1):11-17.
11. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, Emmert M, Baltzer N, Neundörfer B, Schöffski O, Krobot KJ; for the CompetenceNet Stroke. Lifetime cost of ischemic stroke in Germany: results and national projections from a population-based stroke registry: The Erlangen Stroke Project. Stroke. 2006;37:1179-1183.
12. Helsingborg Declaration 2006. Available at: www.donau-uni.ac.at/imperia/ md/content/studium/umwelt_medizin/neuro/helsingborg_decleration_2006.pdf.
13. Teasell R, Foley N, Bhogal S, Bagg S, Jutai J. Evidence-based practice and setting basic standards for stroke rehabilitation in Canada. Top Stroke Rehabili. 2006;13:59-65.
14. Heuschmann PU, Biegler MK, Busse O, Elsner S, Grau A, Hasenbein U, Hermanek P, Janzen RW, Kolominisky-Rabas PL, Kraywinkel K, Lowitzsch K, Misselwitz B, Nabavi DG, Otten K, Pientka L, von Reutern GM, Ringelstein EB, Sander D, Wagner M, Berger K. Development and implementation of evidence-based indicators for measuring quality of acute stroke care: the Quality Indicator Board of the German Stroke Registers Study Group (ADSR). Stroke. 2006;37:2573-2578.
15. Chuang KY, Wu SC, Dai YT, Ma AH. Post-hospital care of stroke patients in Taipei: use of services and policy implications. Health Policy. 2006; [Epub ahead of print].
16. Chuang KY, Wu SC, Yeh MC, Chen YH, Wu CL. Exploring the associations between long-term care and mortality rates among stroke patients. J Nurs Res. 2005;13:66-74.
17. Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL; Telemedic Pilot Project for Integrative Stroke Care Group. Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol. 2006;5:742-748.
18. Audebert HJ, Kukla C, Vatankhah B, Gotzler B, Schenkel J, Hofer S, Furst A, Haberl RL. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke. 2006;37:1822-1827.
19. Hess DC, Wang S, Gross H, Nichols FT, Hall CE, Adams RJ. Telestroke: extending stroke expertise into underserved areas. Lancet Neurol. 2006;5:275-278.
20. Gross H, Hall CE, Wang S, Pardue C, Hess DC, Nichols FT, Adams RJ. Prospective reliability of the STRokE DOC Wireless/Site Independent Telemedicine System. Neurology. 2006;66:460.
21. Hess DC, Wang S, Hamilton W, Lee S, Pardue C, Waller JL, Gross H, Nichols F, Hall C, Adams RJ. REACH: clinical feasibility of a rural telestroke network. Stroke. 2005;36:2018-2020.
22. Choi JY, Porche NA, Albright KC, Khaja AM, Ho VS, Grotta JC. Using telemedicine to facilitate thrombolytic therapy for patients with acute stroke. Jt Comm J Qual Patient Saf. 2006;32:199-205.
23. Simpson CR, Hannaford PC, Lefevre K, Williams D. Effect of the UK incentive-based contract on the management of patients with stroke in primary care. Stroke. 2006;37:2354-2360.
24. Szucs TD, Bramkamp M. Pharmacoeconomics of anticoagulation therapy for stroke prevention in atrial fibrillation: a review. J Thromb Haemost. 2006;4:1180-1185.
25. Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and high risk of stroke in the US. Pharmacoeconomics. 2006;24:1021-1033.
26. Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G, Gough M, Brennan A, Bamford J, Best J. Accurate, practical and cost-effective assessment of carotid stenosis in the UK. Health Technol Assess. 2006;10:1-182.
27. Williams LS, Bakas T Brizendine E, Plue L, Tu W, Hendrie H, Kroenke K. How valid are family proxy assessments of stroke patients' health-related quality of life? Stroke. 2006;37:1179.
28. Xie J, Wu EQ, ZhengZ-J, Croft JB, Greenlund KJ, Mensah GA, Labarthe DR. Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States. Stroke. 2006;37:2567-2572.